Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARIX BIOSCIENCE PLC Regulatory Filings 2018

Jan 3, 2018

4968_rns_2018-01-03_1d7c2d7a-2b83-4efc-9b5a-765d98f82859.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8259A

Arix Bioscience Plc

03 January 2018

3 January 2018

Arix Bioscience plc

Voting Rights and Capital: Month End Disclosure

Pursuant to Disclosure and Transparency Rule 5.6.1:

As at 31 December 2017, the issued share capital of Arix Bioscience plc comprised 96,153,090 ordinary shares of £0.00001 each and 49,671 non-voting C Shares of £1.00 each. There were no shares held in treasury.

The total number of voting rights in Arix Bioscience plc was therefore 96,153,090.

The total voting rights figure may be used by shareholders as the denominator for the calculation by which they will determine whether they are required to notify their interest in, or a change to their interest in, Arix Bioscience plc under the FCA's Disclosure Guidance and Transparency Rules.

For further information, please contact:

James Rawlingson                           Chief Financial Officer                +44 (0)207 290 1050

- Ends -

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCGCGDBSSGBGIX